Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Ahmadinia-Tabesh, Roya
- Assessment of the Risk of Coronary Heart Disease in Diabetes Patients Type-II
Abstract Views :205 |
PDF Views:0
Authors
Affiliations
1 Chronic Diseases [Home Care] Research Center, Hamadan University of Medical Sciences, Hamadan, IR
2 Modeling of No Communicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan,, IR
1 Chronic Diseases [Home Care] Research Center, Hamadan University of Medical Sciences, Hamadan, IR
2 Modeling of No Communicable Diseases Research Center, Hamadan University of Medical Sciences, Hamadan,, IR
Source
Asian Journal of Nursing Education and Research, Vol 9, No 2 (2019), Pagination: 267-270Abstract
Background: Diabetes and Coronary Heart Disease (CHD) are the most common diseases in worldwide. Early diagnosis and modification the risk factors of these diseases are the priorities of the health systems. Objectives: This study aimed to determine the risk of coronary heart disease in patients with type 2 diabetes. Methods: A cross-sectional study was performed. Participates were 112 (56 females and 56 males) patients with type 2 diabetes who referred to the Diabetes Research Center, Hamadan, Iran. In order to assess the risk of CHD in the study group the Framingham risk factors of CHD were used which include age, total cholesterol, HDL, LDL, Triglyceride, Systolic blood pressure, and Type II diabetes. Results: The average risk of CHD in diabetes men was higher than women, which is at a risk of 8% over 5 years and 16% over 10 years, respectively (p<0.05). The risk of CHD in women between 45 to 59 yearwas significantly more than that of the general population. The coronary heart disease was associated with variables of age, gender, systolic and diastolic blood pressure (p <0.05). Conclusion: The risk of coronary heart disease in diabetic patients was high. So, to minimize the risk of coronary heart disease in the society, it is suggested to prioritize the preventive interventions to decrease the modifiable risks of CHD.Keywords
Diabetes Mellitus Type 2, Coronary Artery Disease, Coronary Heart Disease, Heart Diseases.
References
- Parsa P, Ahmadinia-Tabesh R, Mohammadi Y, Khorami N. Investigating the relationship between quality of life with lipid and glucose levels in Iranian diabetic patients. Diabetes & Metabolic Syndrome: Clinical Research and Reviews. 2017; 11:S879-S83.
- Parsa P, Ahmadinia Tabesh R, Soltani F, Karami M, Khorami N. Effects of Group Counseling on Self-care Behaviors in Menopausal Women with Diabetes. Journal of menopausal medicine. 2017; 23:108-16.
- Etemad K, Heidari A, Panahi M, Lotfi M, Fallah F, SadeghiS. A Challenges in Implementing Package of Essential Noncommunicable Diseases Interventions in Iran Health System. Journal of health research in community. 2016; 2:32-43.
- Baljani E, Salimi S, Rahimi J, Amanpour E, Parkhashjou M, Sharifnejad A, et al The effect of education on promoting self efficacy in patients with cardiovascular disease. Journal of Kermanshah University of Medical Sciences. J Kermanshah Univ Med Sci. 2012; 16:227-35.
- Kahn CR. New concepts in the pathogenesis of diabetes mellitus. Advances in internal medicine. 1996; 41:285.
- Kutty BM, Raju T. New vistas in treating diabetes-Insight into a holistic approach. 2010.
- Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, et al. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study [phase 1]. Sozial-und Praventivmedizin/Social and
- Preventive Medicine. 2002; 47:408-26.
- Moller-Leimkuhler AM. Gender differences in cardiovascular disease and comorbid depression. Dialogues in clinical neuroscience. 2007; 9:71.
- Hariri N, Nasseri E, Houshiar-Rad A, Zayeri F, Bondarianzadeh D. Association between Alternative Healthy Eating Index and 10-year risk of cardiovascular diseases in male-employees in the public sector in Tehran, 1391. Iranian Journal of Nutrition Sciences & Food Technology. 2013; 8:41-50.
- Bozorgmanesh M, Hadaegh F, Azizi F. Predictive accuracy of the ‘Framingham’s general CVD algorithm’in a Middle Eastern population: Tehran Lipid and Glucose Study. International journal of clinical practice. 2011; 65:264-73.
- Imanipour M, Bassampour S, Haghani H. Relationship between preventive behaviors and knowledge regarding cardiovascular diseases. Journal of hayat. 2008; 14:41-9.
- Smith SC, Allen J, Blair SN, BonowRO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation. 2006; 113:2363-72.
- Crouch R. Perception, knowledge & awareness of coronaryheart disease among rural Australian women 25 to 65 years of age-a descriptive study 2008.
- American Diabetes Assosiation . Prevention and management of diabetes complications. Diabetes Care. 2012; 35:S28-38.
- Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. American journal of hypertension. 1994; 7:7S-12S.
- Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's Heart Disease E-Book: A Textbook of Cardiovascular Medicine: Elsevier Health Sciences; 2011.
- Anderson KM, Wilson P, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation. 1991; 83:356-62.
- Marcus M, Skorton DJ, Braunwald E. Marcus cardiac imaging: a companion to Braunwald's heart disease: Saunders; 1996.
- Ellis SG, Tamai H, Nobuyoshi M, Kosuga K, Colombo A, Holmes DR, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996. Circulation. 1997; 96:386.
- Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-47.
- Zahedi F, Larijani B. Assessment of the risk of coronary heart disease in patients with type 2 diabetes based on the Framingham study: A cross-sectional risk factor study. Iranian Journal of Diabetes and Lipid Disorders. 2001; 1:73-82.
- Nesto R. Epidemiology of and risk factors for coronary heart disease in diabetesmellitus. UpToDate [Medical], version. 1998;9.
- McGorrian C, Yusuf S, Islam S, Jung H, Rangarajan S, Avezum A, Prabhakaran D, Almahmeed W, et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. European Heart Journal. 2011; 32: 581-90
- Kannel WB, Mcgee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979; 59:8-13.
- Rahmani M, Raiszadeh F, Allahverdian S, Kiaii S, Navab M, Azizi F. Coronary artery disease is associated with the ratio of apolipoprotein AI/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects. Atherosclerosis. 2002; 162:381-9.
- Rasouli M, Mohseni Kiasari A, Mokhberi V, BagheriB, Daneshpour NS, Shariati R, et al. Global risk assessment of coronary heart disease using Framingham's scores for major risk factors. Journal of Mazandaran University of Medical Sciences. 2006; 15:49-62.
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003; 289:2560-71.
- Dunkley A, Charles K, Gray L, Camosso Stefinovic J, Davies M, Khunti K. Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta analysis. Diabetes, Obesity and Metabolism. 2012; 14: 616-25.